
6382 - Leave requirement - LII / Legal Information Institute
Subject to section 6383, an employee who is the spouse, son, daughter, parent, or next of kin of a covered servicemember shall be entitled to a total of 26 administrative workweeks of leave …
About VA Form 26-6382 - Veterans Affairs
2023年10月19日 · Find out how to update your direct deposit information online for disability compensation, pension, or education benefits. Find out how to change your address and other …
LEGO 6382 Fire Station Instructions and Parts List
Instructions and parts list for LEGO 6382 Fire Station at ToysPeriod's LEGO Database.
Paid Parental Leave - U.S. Office of Personnel Management
The Federal Employee Paid Leave Act (Public Law 116-92, December 20, 2019, as codified under the Family and Medical Leave Act provisions at 5 U.S.C. 6382) provides an employee …
6382 - Gene ResultSDC1 syndecan 1 [ (human)] - National Center …
Gene ID: 6382, updated on 9-Feb-2025. Summary. The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan …
5 USC 6382: Leave requirement - House
§6382. Leave requirement (a)(1) Subject to section 6383, an employee shall be entitled to a total of 12 administrative workweeks of leave during any 12-month period for one or more of the …
Strong's Hebrew: 6382. פֶּ֫לֶא (pele) -- Wonder, Marvel, Miracle
Strong's Hebrew: 6382. פֶּ֫לֶא (pele) -- Wonder, Marvel, Miracle. Word Origin: From the root פָּלָא (pala), which means "to be wonderful" or "to be extraordinary." Usage: The Hebrew word …
5 U.S.C. § 6382 (2023) - Leave requirement - Justia Law
5 U.S.C. § 6382 (2023) Section Name §6382. Leave requirement: Section Text (a)(1) Subject to section 6383 and subsection (d)(2) of this section, an employee shall be entitled to a total of …
INSTRUCTIONS: Please complete this form and the VA Form 26-6807, Financial Statement, and return to the office of the Department of Veterans Affairs shown below.
RG-6382 by F. Hoffmann-La Roche for Systemic Lupus …
2025年1月21日 · RG-6382 (RO-7507062) is under development for the treatment of systemic lupus erythematosus (SLE). The drug candidate is administered through subcutaneous route …